Zepbound vs Wegovy: which works better and which is easier to get online?

Zepbound (tirzepatide) works better for weight loss, achieving approximately 20–21% body weight reduction compared to Wegovy (semaglutide) at 13–14% in head-to-head trials [1][2][5]. However, Wegovy is likely easier to get online for most people because it has a longer track record, is approved for adolescents (12+), has more cardiovascular data, and is available in both injectable and pill forms, whereas Zepbound is only an injection and currently approved only for adults (18+) [2][3][6].

Which Works Better?

• Higher Weight Loss: Zepbound users lost about 47% more weight than Wegovy users in clinical trials, with averages of 20.2% vs. 13.7% over 72 weeks [1][5].
• Dual Mechanism: Zepbound is a "dual-agonist" targeting both GLP-1 and GIP hormones, while Wegovy targets only GLP-1, which explains its superior efficacy [2][6].
• Specific Benefits: Zepbound is proven to reduce obstructive sleep apnea severity [2][3], while Wegovy has stronger data for cardiovascular risk reduction in adults with heart disease and is approved for MASH/fatty liver [2][6].
• Tolerance: Some patients tolerate Zepbound better if they experience excessive fatigue on Wegovy, though both have similar side effects (nausea, constipation) and fewer Zepbound users discontinue treatment due to adverse events [4][5].

Which Is Easier to Get Online?

• Availability & Form: Wegovy is available as both an injection and a pill, offering greater flexibility for online telehealth services that may not support injectable disposal logistics for new patients [3]. Zepbound is only an injection [3].
• Insurance & Coverage: Wegovy often has better insurance coverage and a longer history of being covered by major plans, whereas Zepbound costs hundreds of dollars monthly for many due to limited weight-loss coverage [7]. A new Medicare program offers Zepbound for $50/month for those 65+, but this is age-specific [7].
• Age Restrictions: Wegovy is FDA-approved for adolescents 12–17, making it the accessible option for younger patients online, while Zepbound is restricted to 18+ [2][6].
• Market Presence: Wegovy has a "longer track record" and more established supply chains, potentially leading to fewer online stock shortages compared to the newer Zepbound [2][8].

Recommendation

• Choose Zepbound if: Your primary goal is maximum weight loss, you have obstructive sleep apnea, you are over 18, and your insurance covers it well [2].
• Choose Wegovy if: You need cardiovascular risk reduction, you are an adolescent (12–17), you prefer the pill form, or you want the medication with the most established insurance coverage and online availability [2][6].

For online access, start by checking your local pharmacy availability and insurance coverage for Wegovy, as it is generally the more accessible option currently [8]. Always consult a doctor before starting either medication [2].